Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina
<p>Abstract</p> <p>Background</p> <p>Chronic refractory angina is a challenging clinical problem with limited treatment options. The results of early cardiovascular stem cell trials using ABMMC have been promising but have utilized intracoronary or intramyocardial deliv...
Main Authors: | Ercilla Jose, Carrillo Alvaro, Cruz Carlos, Castillo Jorge, Carrasco Antonio, Fernández-Viña Roberto, Tuma Jorge, Yarleque Carlos, Cunza Jaime, Henry Timothy D, Patel Amit N |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/9/1/183 |
Similar Items
-
Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina?
by: Daniela Benedetto, et al.
Published: (2016-10-01) -
RESCUE-HF Trial: Retrograde Delivery of Allogeneic Umbilical Cord Lining Subepithelial Cells in Patients with Heart Failure
by: Jorge Tuma, et al.
Published: (2016-09-01) -
Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy
by: Hong Mao, et al.
Published: (2019-01-01) -
Coronary sinus intervention for the treatment of refractory angina pectoris
by: Paz Y, et al.
Published: (2011-03-01) -
Effectiveness of percutaneous laser revascularization therapy for refractory angina
by: Michael McGillion, et al.
Published: (2010-08-01)